FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule


2007P-0216: Determine that an Additional Dosage of Deferoxamine Mesylate for Injection, USP is Suitable for an Abbreviated New Drug Application (ANDA)

Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
CP1 05/30/2007 05/30/2007 Private Industry Ben Venue Laboratories, Inc. html
Signature: Molly L. Rapp
ACK1 05/30/2007 05/30/2007 Federal Government
FDA/DDM to Ben Venue Laboratories, Inc. pdf
Signature: Gloria Ortega

Top |

Page last updated: June 1, 2007